Data443 Risk Mitigation (ATDS) 10-Q 15 May 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 14, 2020
Document And Entity Information
Entity Registrant Name	Data443 Risk Mitigation, Inc.
Entity Central Index Key	0001068689
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	No
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		52,061,034
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets
Cash	$ 69,643	$ 18,673
Accounts receivable	31,366	63,556
Inventory	8,301	8,301
Prepaid expense and other current assets	565	807
Total current assets	109,875	91,337
Property and equipment, net	250,779	100,127
Operating lease right-of-use assets, net	376,565	395,388
Intellectual property, net of accumulated amortization	2,703,000	3,141,938
Deposits	31,440	20,944
TOTAL ASSETS	3,471,659	3,749,734
Current Liabilities
Accounts payable	308,484	379,325
Payroll liabilities	18,335	28,870
Deferred revenues	1,031,939	728,749
Interest payable	63,307	59,979
Note payable	179,110	165,120
Convertible notes payable, net of unamortized discount	3,160,380	3,212,786
Derivative liability	10,711,264	2,601,277
Due to a related party	1,160,793	1,103,314
License fee payable	1,094,691	1,094,691
Operating lease liability	89,017	86,372
Finance lease liability	81,987	34,425
Total Current Liabilities	17,899,307	9,494,908
Deferred revenues - non-current	114,554	224,797
Operating lease liability - non-current	349,404	373,000
Finance lease liability - non-current	155,698	53,480
TOTAL LIABILITIES	18,518,963	10,146,185
Stockholders' deficit
Preferred stock: 337,500 authorized; $0.001 par value 1,334 shares issued and outstanding	1	1
Common stock: 250,000,000 authorized; $0.001 par value 19,482,091 and 9,692,065 shares issued and outstanding, respectively	19,482	9,692
Additional paid in capital	16,725,143	15,204,771
Accumulated deficit	(31,791,930)	(21,610,915)
Total stockholders' deficit	(15,047,304)	(6,396,451)
Total Liabilities and stockholders' deficit	$ 3,471,659	$ 3,749,734

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2020	Mar. 05, 2020	Dec. 31, 2019	Oct. 14, 2019
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	337,500		337,500
Preferred stock, par value	$ 0.001		$ 0.001	$ 0.001
Preferred stock, shares issued	1,334		1,334
Preferred stock, shares outstanding	1,334		1,334
Common stock, shares authorized	250,000,000	250,000,000	250,000,000
Common stock, par value	$ 0.001		$ 0.001
Common stock, shares issued	19,482,091		9,692,065
Common stock, shares outstanding	19,482,091		9,692,065

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue	$ 477,877	$ 142,791
Cost of revenue	(34,289)	(20,551)
Gross profit	443,588	122,240
Operating expenses
General and administrative	1,425,234	675,499
Sales and marketing	120,818	225,687
Research and development		4,205
Total operating expenses	1,546,052	905,391
Net loss from operations	(1,102,464)	(783,151)
Other income (expense)
Interest expense	(518,400)	(299,899)
Gain on contingent liability		300,000
Loss on settlement on debt	(54,000)
Change in fair value of derivative liability	(8,506,151)	6,813,153
Total other income (expense)	(9,078,551)	6,813,254
Income (loss) before income taxes	(10,181,015)	6,030,103
Provision for income taxes
Net income (loss)	$ (10,181,015)	$ 6,030,103
Basic income (loss) per Common Share	$ (0.70)	$ 0.81
Basic weighted average number of common shares outstanding	14,542,721	7,399,376
Diluted income (loss) per Common Share	$ (0.70)	$ 0.78
Diluted weighted average number of common shares outstanding	14,542,721	7,770,738

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)	Convertible Preferred Series A [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2018	$ 1	$ 6,816	$ 8,689,353	$ (21,003,544)	$ (12,307,374)
Balance, shares at Dec. 31, 2018	1,334	6,816,281
Common stock issued for conversion of debt		$ 558	499,442		500,000
Common stock issued for conversion of debt, shares		557,942
Share-based compensation			45,007		45,007
Share-based compensation, shares
Settlement of stock subscriptions		$ 336	(336)
Settlement of stock subscriptions, shares		336,020
Warrants on stock subscriptions			(167,544)		(167,544)
Common issued to settle debt		$ 667	1,694,333		1,695,000
Common issued to settle debt, shares		666,665
Net income loss				6,030,103	6,030,103
Balance at Mar. 31, 2019	$ 1	$ 8,377	10,760,255	(14,973,441)	(4,204,808)
Balance, shares at Mar. 31, 2019	1,334	8,376,908
Balance at Dec. 31, 2019	$ 1	$ 9,692	15,204,771	(21,610,915)	(6,396,451)
Balance, shares at Dec. 31, 2019	1,334	9,692,065
Common stock issued for conversion of debt		$ 6,824	1,317,686		1,324,510
Common stock issued for conversion of debt, shares		6,824,272
Stock issued for asset acquisition		$ 2,466	(2,466)
Stock issued for asset acquisition, shares		2,465,754
Share-based compensation		$ 500	205,152		$ 205,652
Share-based compensation, shares		500,000			159,767
Net income loss				(10,181,015)	$ (10,181,015)
Balance at Mar. 31, 2020	$ 1	$ 19,482	$ 16,725,143	$ (31,791,930)	$ (15,047,304)
Balance, shares at Mar. 31, 2020	1,334	19,482,091

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (10,181,015)	$ 6,030,103
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative liability	8,506,151	(6,813,153)
Loss on impairment of asset
Gain on contingent liability		(300,000)
Loss on settlement of debt	54,000
Share-based compensation expense	205,652	45,007
Depreciation and amortization	450,359	253,196
Amortization of debt discount	437,639	273,742
Bad debt expense	50,800
Changes in operating assets and liabilities:
Accounts receivable	(18,610)	(301,067)
Inventory		(192)
Prepaid expenses and other assets	242	(1,833)
Accounts payable	(70,841)	126,697
Deferred revenues	192,947	273,731
Payroll liability	(10,535)	16,525
Accrued interest	52,999	26,157
Due to related parties		7,986
Operating lease payments	(2,128)	27,871
Accrued consulting expense
Deposit paid	(10,496)	(10,000)
Net Cash used in Operating Activities	(342,836)	(345,230)
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of intellectual property		(235,000)
Purchase of property and equipment	(4,068)	(3,965)
Net Cash used in Investing Activities	(4,068)	(238,965)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of convertible notes payable	497,250
Proceeds from issuance of stock and member distributions		500,000
Capital lease payments	(8,225)
Proceeds from issuance of notes payable	189,615
Repayment of notes payable	(203,245)	(225,000)
Proceeds from related parties	83,204
Repayment to related parties	(160,725)
Net Cash provided by Financing Activities	397,874	275,000
Net change in cash	50,970	(309,195)
Cash, beginning of year	18,673	324,935	$ 324,935
Cash, end of year	69,643	15,740	$ 18,673
Supplemental cash flow information
Cash paid for interest	27,653
Cash paid for taxes
Non-cash Investing and Financing transactions:
Settlement of accrued interest through issuance of convertible notes payable		25,000
Settlement of convertible notes payable through issuance of common stock	427,671
Resolution of derivative liability upon conversion of debt	896,839
Equipment paid by capital lease	158,005
Derivative liability recognized as debt discount	$ 500,675

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business Description Data443 Risk Mitigation, Inc. (the “Company”) was incorporated as a Nevada corporation on May 4, 1998. The Company is developing products that enable secure data, at rest and in flight, across local devices, network, cloud, and databases. On October 15, 2019, the Company changed its name from LandStar, Inc. to Data443 Risk Mitigation, Inc. within the state of Nevada. Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements as of March 31, 2020 include the accounts of the Company and its wholly-owned subsidiary, Data 443 Risk Mitigation, Inc., a North Carolina operating company, and the operations of Myriad Software Productions, LLC through September 2018 when it was liquidated. Prior to the acquisition of Data 443 Risk Mitigation, Inc. in North Carolina and the assets of Myriad Software Productions, LLC in 2018, these two entities were controlled by our sole director and officer, Jason Remillard. On November 17, 2017, Mr. Remillard acquired control of DATA443 RISK MITIGATION, INC. through his purchase of all the outstanding Series A preferred shares of the Company, and as a result, these two entities became common controlled entities that require consolidation of results with the reporting company, DATA443 RISK MITIGATION, INC., from the time common control occurred. All intercompany accounts and activities have been eliminated. These consolidated financial statements have been prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). Interim Financial Statements These unaudited consolidated financial statements have been prepared in accordance U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2019 and notes thereto and other pertinent information contained in our Form 10-K the Company has filed with the Securities and Exchange Commission (the “SEC”) on April 17, 2020. The results of operations for the three months ended March 31, 2020, are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2020. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Revenue Recognition The Company derives revenue primarily from contracts for subscription to access our SaaS platforms and, to a much lesser degree, ancillary services provided in connection with subscription services. The Company’s contracts include the performance obligations that require us to provide access to the platforms, usually on an annual subscription. The Company’s contracts are for subscriptions to DataExpress TM TM TM TM Revenue related to contracts with customers is evaluated utilizing the following steps: (i) Identify the contract, or contracts, with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; (v) Recognize revenue when the Company satisfies a performance obligation. Deferred Revenue Deferred revenue mostly consists of service subscriptions received from users in advance of revenue recognition. The deferred revenue balance for the period ended March 31, 2020 was driven by cash payments from customers in advance of satisfying our performance obligations, offset by revenue recognized that was included in the deferred revenue balance at the beginning of the period. Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP. When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument. Common stock purchase warrants and derivative financial instruments - Beneficial Conversion Feature Share-Based Compensation Employees Nonemployees The Company recorded $205,652 in share-based compensation expense for the three months ended March 31, 2020, compared to $45,007 in share-based compensation expense for the three months ended March 31, 2019. Fair Value Measurements The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows: ● Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets; ● Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and ● Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions. The Company’s financial instruments, including cash, accounts receivable, accounts payable, note payable, due to related parties and accrued liabilities, are carried at historical cost. At March 31, 2020 and December 31, 2019, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Management determined that liabilities created by beneficial conversion features associated with the issuance of certain convertible notes payable (see Note 6), meet the criteria of derivatives and are required to be measured at fair value. The fair value of these derivative liabilities was determined based on management’s estimate of the expected future cash flows required to settle the liabilities. This valuation technique involves management’s estimates and judgment based on unobservable inputs and is classified in level 3. Basic and Diluted Net Income (Loss) Per Common Share Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and as if converted method. Dilutive potential common shares include outstanding stock options, warrant and convertible notes. For the three months ended March 31, 2020 and 2019, respectively, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. March 31, 2020 2019 Stock option 466,672 179,443 Warrants 69,714,754 - Convertible notes 144,106,172 2,625,093 214,287,598 2,804,536 COVID-19 A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company has instituted some and may take additional temporary precautionary measures intended to help ensure the well-being of its employees and minimize business disruption. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at March 31, 2020. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to collect accounts receivable and procure materials and supplies. CARES Act The Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was enacted on March 27, 2020. There are several different provisions of the CARES Act that impact income taxes for corporations. While the Company continues to evaluate the tax implications, it believes these provisions will not have a material impact to the financial statements. Additionally, the Company has applied for, and has received, funds under the Paycheck Protection Program (the “PPP Loan”) after the period covered in these financial statements in the amount of $339,000. The receipt of these funds, and the forgiveness of the loan attendant to these funds, is dependent on the Company having initially qualified for the loan and qualifying for the forgiveness of such loan based on its future adherence to the forgiveness criteria. The PPP Loan has a two-year term and bears interest at a rate of 1.0% per annum. Monthly principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The promissory note executed by the Company in connection with the PPP Loan contains events of default and other provisions customary for a loan of this type. The PPP Loan is being used to retain the Company’s employees and allow them to be able to continue to provide essential services for the customers of the Company. Proceeds of the PPP Loan may also be used for other purposes permitted under applicable terms of the PPP. Certain prior period balances have been reclassed to conform with the current period presentation.

Liquidity and Going Concern

Liquidity and Going Concern	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity and Going Concern	NOTE 2: LIQUIDITY AND GOING CONCERN The accompanying consolidated financial statements have been prepared (i) in accordance with accounting principles generally accepted in the United States, and (ii) assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. After a period of no income, the Company has recently generated increasing income. However, the Company is subject to the risks and uncertainties associated with a business with growing revenue, as well as limitations on its operating capital resources. These matters, among others, raise substantial doubt about the ability of the Company to continue as a going concern. These consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern. In light of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to raise capital and generate revenue and profits in the future. During 2018, the Company made two product acquisitions, ClassiDocs, and ARALOC TM TM We continue to monitor the effects COVID-19 could have on our operations and liquidity including our ability to collect account receivable timely from our customers due to the economic impacts COVID-19 could have on the general economy. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Intellectual Property

Intellectual Property	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intellectual Property	NOTE 3: INTELLECTUAL PROPERTY The following table summarizes the components of the Company’s intellectual property as of the dates presented: March 31, December 31, 2020 2019 Intellectual property: Word press GDPR rights $ 46,800 $ 46,800 ARALOC™ 1,850,000 1,850,000 ArcMail License 1,445,000 1,445,000 DataExpressTM 1,388,051 1,388,051 4,729,851 4,729,851 Accumulated amortization (2,026,851 ) (1,587,913 ) Intellectual property, net of accumulated amortization $ 2,703,000 $ 3,141,938 The Company recognized amortization expense of approximately $438,938 and $253,000, for the three months ended March 31, 2020, and 2019, respectively. Based on the carrying value of definite-lived intangible assets as of March 31, 2020, we estimate our amortization expense for the next five years will be as follows: Amortization Year Ended December 31, Expense 2020 (excluding the three months ended March 31, 2020) $ 915,428 2021 792,422 2022 686,816 2023 308,333 2024 -

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	NOTE 4: LEASES Operating lease We have a non-cancelable operating lease for our office facility that expire in 2024. The operating lease has renewal options and rent escalation clauses. We recognized total lease expense of approximately $27,871 and $27,871 for the three months ended March 31, 2020 and 2019, respectively, primarily related to operating lease costs paid to lessors from operating cash flows. As of March 31, 2020 and December 31, 2019, the Company recorded a security deposit of $10,000. We entered into our operating lease in January 2019. Future minimum lease payments under operating leases that have initial non-cancelable lease terms in excess of one year at March 31, 2020 were as follows: Year Ended December 31, 2020 (excluding the three months ended March 31, 2020) $ 90,000 2021 123,600 2022 127,300 2023 131,150 2024 45,033 Thereafter - 517,083 Less: Imputed interest (78,662 ) Operating lease liabilities 438,421 Operating lease liability – current 89,017 Operating lease liability - non-current $ 349,404 The following summarizes other supplemental information about the Company’s operating lease as of March 31, 2020: Weighted average discount rate 8 % Weighted average remaining lease term (years) 4.11 Finance lease The Company leases computer and hardware under non-cancellable capital lease arrangements. The term of those capital leases is 3 years and annual interest rate is 12%. At March 31, 2020 and December 31, 2019, capital lease obligations included in current liabilities were $81,987 and $34,425, respectively, and capital lease obligations included in long-term liabilities were $155,698 and $53,480, respectively. As of March 31, 2020 and December 31, 2019, the Company recorded a security deposit of $10,944. At March 31, 2020, future minimum lease payments under the capital lease obligations, are as follows: Year Ended December 31, 2020 (excluding the three months ended March 31, 2020) $ 79,573 2021 106,097 2022 78,197 2023 15,744 Thereafter - 279,611 Less: Imputed interest (41,926 ) Finance lease liabilities 237,685 Finance lease liability – current 81,987 Finance lease liability - non-current $ 155,698

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Convertible Notes Payable	NOTE 5: CONVERTIBLE NOTES PAYABLE Convertible notes payable consists of the following: March 31, December 31, 2020 2019 Convertible Note - originated in September 2018 $ 1,400,000 $ 1,700,000 Convertible Note - originated in October 2018 294,150 444,150 Convertible Note - originated in October 2018 608,850 608,850 Convertible Note - originated in April 2019 519,000 600,000 Convertible Note - originated in June 2019 - 63,000 Convertible Note - originated in November 2019 38,000 38,000 Convertible Note - originated in December 2019 38,000 38,000 Convertible Notes - originated in January 2020 200,000 - Convertible Notes - originated in March 2020 136,250 - Convertible Notes - originated in March 2020 78,750 - Convertible Notes - originated in October 2018 (replacement) 135,000 - Convertible Notes - originated in March 2020 125,000 - 3,573,000 3,492,000 Less debt discount and debt issuance cost (412,620 ) (279,214 ) 3,160,380 3,212,786 Less current portion of convertible notes payable 3,160,380 3,212,786 Long-term convertible notes payable $ - $ - During the three months ended March 31, 2020 and 2019, the Company recognized interest expense of $53,517 and $26,157, and amortization of debt discount, included in interest expense of $410,019 and $273,742, respectively. Replacement of note During the three months ended March 31, 2020, the Company assigned a portion of note with outstanding principal amounts of $150,000 to a lender. Our CEO paid $135,000 to repay a principal amount of $81,000 on behalf of the company. As a result, the Company recorded due to related party of $135,000 and loss on settlement of debt of $54,000. Conversion During the three months ended March 31, 2020, the Company converted notes with principal amounts and accrued interest of $427,671 into 6,824,272 shares of common stock. The corresponding derivative liability at the date of conversion of $896,839 was credited to additional paid in capital. Convertible notes payable consists of the following: Promissory Notes - Issued in fiscal year 2018 On December 31, 2019, the Company entered into an Amendment and Forbearance Agreement with note holders. Under this agreement, note holders agreed to forbear from enforcing its rights under the note with regard to certain possible events of default, and further agreed to amend the note as follows: ● Terms ranging from 4 months to 15 months. ● Annual interest rates: 12%. ● Convertible at the option of the holders at earlier of (i) January 12, 2020 or April 15, 2020 or (ii) any event of default under the note. ● The conversion price shall be equal to 60% of the lesser of the lowest trading price of the Company’s common stock for (i) the 20 days immediately preceding December 31, 2019 or (ii) the 20 days immediately preceding the date of conversion. As a result of an amendment and forbearance agreement, the Company recognized the settlement of original debt and recorded loss on settlement of debt of $1,206,329 during the year ended December 31, 2019. Promissory Notes - Issued in fiscal year 2019 During the year ended December 31, 2019, the Company issued a total of $739,000 of notes with the following terms: ● Terms: 12 months. ● Annual interest rates of 10% - 12%. ● Convertible at the option of the holders at 4 months or 180 days after issuance date. ● Conversion prices are typically based on the discounted (39% to 50% discount) average closing prices or lowest trading prices of the Company’s shares during various periods prior to conversion. ● Certain note allows the principal amount will increase by $15,000 and the discount rate of conversion price will decrease by 10% if the conversion price is less than $$0.005. As a result, the discount rate of conversion price changed from 50% to 60% and the Company recognized the penalty of $15,000 and recorded principal amount of $15,000. The note includes original issue discounts and financing costs totaling to $63,000 and the Company received cash of $676,000. Convertible notes issued in fiscal year 2018 are currently in default. Promissory Notes - Issued in fiscal year 2020 During the three months ended March 31, 2020, the Company issued a total of $540,000 of notes with the following terms: ● Terms ranging from 9 months to 12 months. ● Annual interest rates of 10% - 12%. ● Convertible at the option of the holders at issuance date or 6 months after issuance date. ● Conversion prices are typically based on the discounted (35% to 50% discount) average closing prices or lowest trading prices of the Company’s shares during various periods prior to conversion. Certain note has a fixed conversion price of $0.5 for a first 5 months ● Certain note allows the principal amount will increase by $15,000 and the discount rate of conversion price will decrease by 18% if the conversion price is less than $$0.01. The Company determined that the conversion features, in the convertible notes, met the definition of a liability in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock and therefore bifurcated the embedded conversion options once the notes becomes convertible and accounted for it as a derivative liability. The fair value of the conversion feature was recorded as a debt discount and amortized to interest expense over the term of the note. The Company valued the conversion feature using the Binomial pricing model. The fair value of the derivative liability for all the notes that became convertible, including the notes issued in prior years, during the three months ended March 31, 2020 amounted to $6,092,869, and $500,675 of the value assigned to the derivative liability was recognized as a debt discount to the notes while the balance of $5,592,194 was recognized as a “day 1” derivative loss.

Derivative Liabilities

Derivative Liabilities	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	NOTE 6: DERIVATIVE LIABILITIES The Company analyzed the conversion option for derivative accounting consideration under ASC 815, Derivatives and Hedging, and hedging, and determined that the instrument should be classified as a liability since the conversion option becomes effective at issuance resulting in there being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options. ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item. The Company determined our derivative liabilities to be a Level 3 fair value measurement and used the Binomial pricing model to calculate the fair value as of March 31, 2020. The Binomial model requires six basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each convertible note and warrant is estimated using the Binomial valuation model. For the period ended March 31, 2020 and the year ended December 31, 2019, the estimated fair values of the liabilities measured on a recurring basis are as follows: Three Months Ended Year Ended March 31, December 31, 2020 2019 Expected term 0.02 - 5.00 years 0.25 - 5.00 years Expected average volatility 187%- 345 % 160%- 305 % Expected dividend yield - - Risk-free interest rate 0.01% - 1.57 % 1.55% - 2.50 % The following table summarizes the changes in the derivative liabilities during the period ended March 31, 2020: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Derivative liability as of December 31, 2019 $ 2,601,277 Addition of new derivatives recognized as debt discounts 500,675 Addition of new derivatives recognized as day-one loss 5,592,194 Addition of new derivatives recognized upon issuance of warrant - Derivative liabilities settled upon conversion of convertible note (896,839 ) Reclassification from APIC to derivative due to tainted instruments - Change in derivative liabilities recognized as loss on derivative 2,913,957 Derivative liability as of March 31, 2020 $ 10,711,264 The aggregate gain (loss) on derivatives during the three months ended March 31, 2020 and 2019 was ($8,506,151) and $6,813,153, respectively.

Capital Stock and Reverse Stock

Capital Stock and Reverse Stock Split	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Capital Stock and Reverse Stock Split	NOTE 7: CAPITAL STOCK AND REVERSE STOCK SPLIT Changes in Authorized Shares On October 14, 2019, the Company filed an amendment to its Articles of Incorporation to effect a 1-for-750 reverse stock split of its issued and outstanding shares of common and preferred shares, each with $0.001 par value. All per share amounts and number of shares, in the consolidated financial statements and related notes have been retroactively adjusted to reflect the reverse stock split. On March 5, 2020, the Company amended its Articles of Incorporation to increase the number of shares of authorized common stock to 250,000,000. Preferred Stock As of March 31, 2020, the Company is authorized to issue 337,500 shares of preferred stock with a par value of $0.001, of which 337,500 shares have been designated as Series A. As of March 31, 2020 and December 31, 2019, 1,334 shares of Series A were issued and outstanding, and each share of Series A was (i) convertible into 1,000 shares of common stock, and (ii) entitled to vote 15,000 shares of common stock on all matters submitted to a vote by shareholders voting common stock. All issued and outstanding shares of Series A Preferred Stock are held by Mr. Jason Remillard, (“Mr. Remillard”) sole director of the Company. Common Stock The Company is authorized to issue 250,000,000 shares of common stock with a par value of $0.001. All shares have equal voting rights, are non-assessable, and have one vote per share. The total number of shares of Company common stock issued and outstanding as of March 31, 2020 and December 31, 2019, respectively, was 19,482,091 and 9,692,065 shares, respectively. During the three months ended March 31, 2020, the Company issued common stock as follows, ● 6,824,272 shares issued for conversion of debt ● 2,465,754 shares issued for the settlement of stock payable of acquisition DataExpress TM ● 500,000 shares issued for compensation to our former CFO Warrants The Company identified conversion features embedded within warrants issued during the period ended March 31, 2020. The Company has determined that the conversion feature of the Warrants represents an embedded derivative since the conversion price includes a reset provision which could cause adjustments upon conversion. During the three months ended March 31, 2020, 250,000 warrants were granted, for a period of five years from issuance, at price of $0.50 per share. As a result of the reset features, the warrants increased by 67,591,070 for the period ended March 31, 2020, and the total warrants exercisable into 69,714,754 shares of common stock at a weighted average exercise price of $0.015 per share as of March 31, 2020. The reset feature of warrants was effective at the time that a separate convertible instrument with lower exercise price was issued. We accounted for the issuance of the Warrants as a derivative. A summary of activity during the period ended March 31, 2020 follows: Warrants Outstanding Weighted Average Shares Exercise Price Outstanding, December 31, 2019 1,873,684 $ 0.491 Granted 250,000 - Reset feature 67,591,070 0.015 Exercised - - Forfeited/canceled - - Outstanding, March 31, 2020 69,714,754 $ 0.015 The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2020: Warrants Outstanding Warrants Exercisable Weighted Average Number of Contractual life Weighted Average Number of Weighted Average 10,080,646 3.70 $ 0.02 10,080,646 $ 0.02 42,226,702 3.85 $ 0.02 42,226,702 $ 0.02 9,074,073 4.28 $ 0.02 9,074,073 $ 0.02 8,333,333 4.97 $ 0.02 8,333,333 $ 0.02 69,714,754 4.02 $ 0.02 61,381,421 $ 0.02

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Share-Based Compensation	NOTE 8: SHARE-BASED COMPENSATION Stock Options During the three months ended March 31, 2020, the Company granted options for the purchase of the Company’s common stock to certain employees, consultants and advisors as consideration for services rendered. The terms of the stock option grants are determined by the Company’s Board of Directors. The Company’s stock options generally vest upon the one-year anniversary date of the grant and have a maximum term of ten years. The following summarizes the stock option activity for the three months ended March 31, 2020: Options Outstanding Weighted-Average Balance as of December 31, 2019 377,227 $ 1.86 Grants of stock options 159,767 0.26 Cancelled stock options (70,316 ) 1.10 Balance as of March 31, 2020 466,678 $ 1.38 The weighted average grant date fair value of stock options granted during the three months ended March 31, 2020 was $1.35. The total fair value of stock options that granted during the three ended March 31, 2020 was approximately $46,638. The fair value of each stock option is estimated on the date of grant using the Black-Scholes-Merton option pricing model with the following weighted average assumptions for stock options granted during the three months ended March 31, 2020: Expected term (years) 5.8 Expected stock price volatility 516.41 % Weighted-average risk-free interest rate 0.53 % Expected dividend $ 0.00 Volatility is a measure of the amount by which a financial variable such as share price has fluctuated (historical volatility) or is expected to fluctuate (expected volatility) during a period. The Company estimates expected volatility giving primary consideration to the historical volatility of its common stock. The risk-free interest rate is based on the published yield available on U.S. Treasury issues with an equivalent term remaining equal to the expected life of the stock option. The expected lives of the stock options represent the estimated period of time until exercise or forfeiture and are based on the simplified method of using the mid-point between the vesting term and the original contractual term. The following summarizes certain information about stock options vested and expected to vest as of March 31, 2020: Number of Weighted-Average Remaining Contractual Life Weighted-Average Options (In Years) Exercise Price Outstanding 466,678 8.54 $ 1.38 Exercisable 126,926 5.82 3.63 Expected to vest 339,746 9.55 $ 0.54 As of March 31, 2020 and December 31, 2019, there was $65,248 and $18,229, respectively, of total unrecognized compensation cost related to non-vested share-based compensation arrangements which is expected to be recognized within the next year. Restricted Stock Awards During the three months ended March 31, 2020, the Company issued restricted stock awards for shares of common stock which have been reserved for the holders of the awards. Restricted stock awards were issued to certain consultants and advisors as consideration for services rendered. The terms of the restricted stock units are determined by the Company’s Board of Directors. The Company’s restricted stock shares generally vest over a period of one year and have a maximum term of ten years. The following summarizes the restricted stock activity for the three months ended March 31, 2020: Weighted-Average Shares Fair Value Balance as of December 31, 2019 524,337 $ 0.79 Shares of restricted stock granted 25,000 0.78 Exercised - 1.67 Cancelled (72,145 ) 0.95 Balance as of March 31, 2020 477,192 $ 0.79 March 31, December 31, Number of Restricted Stock Awards 2020 2019 Vested 100,978 57,243 Non-vested 376,214 467,094 As of March 31, 2020 and December 31, 2019, there was $61,001 and $147,743, respectively, of total unrecognized compensation cost related to non-vested share-based compensation, which is expected to be recognized over the next year.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 9: RELATED PARTY TRANSACTIONS Jason Remillard is our Chief Executive Officer and sole director. Through his ownership of Series A Preferred Shares, Mr. Remillard has voting control over all matters to be submitted to a vote of our shareholders. In January 2018 the Company acquired substantially all of the assets of Myriad Software Productions, LLC, which is owned 100% by Mr. Remillard. Those assets were comprised of the software program known as ClassiDocs, and all intellectual property and goodwill associated therewith. This acquisition changed the Company’s status to no longer being a “shell” under applicable securities rules. In consideration for the acquisition, the Company agreed to a purchase price of $1,500,000 comprised of: (i) $50,000 paid at closing; (ii) $250,000 in the form of our promissory note; and (iii) $1,200,000 in shares of our common stock, valued as of the closing, which equated to 1,600,000 shares of our common stock. The shares have not yet been issued and are not included as part of the issued and outstanding shares of the Company. However, these shares have been recorded as additional paid in capital within our consolidated financial statements for the period ending March 31, 2020. On September 16, 2019, the Company entered into an Asset Purchase Agreement with DMBGroup, LLC, as discussed in Note 2. Amounts owed to DMBGroup, LLC including the note payable of $940,000 and member loans of $97,689 were recorded as amounts due to a related party. During the three months ended March 31, 2020, the Company repaid $83,323 including interest expense of $8,098, and member loans of $75,225. As of March 31, 2020 and December 31, 2019, the company had recorded a liability to DMBGroup totaling $715,441 and $828,561, respectively. During the three months ended March 31, 2020, our CEO paid operating expenses of $82,203 on behalf of the Company and the Company repaid $85,500 to our CEO. During the three months ended March 31, 2020, our CEO repaid $135,000 to purchase convertible note of $81,000 and a prepayment penalty of $54,000. As a result, the Company recorded $54,000 as loss on settlement of debt. As of March 31, 2020 and December 31, 2019, the Company had due to related party of $1,160,793 and $1,103,314

Net Income Per Common Share

Net Income Per Common Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Net Income Per Common Share	NOTE 10: NET INCOME PER COMMON SHARE Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding during the periods. Diluted net income per common share is computed using the weighted average number of common and dilutive common equivalent shares outstanding during the periods. Common equivalent shares consist of stock options, unvested restricted shares, and outstanding warrants that are computed using the treasury stock method. Antidilutive stock awards consist of stock options that would have been antidilutive in the application of the treasury stock method. Three months ended March 31, 2020 2019 Numerator: Net income (loss) $ (10,157,643 ) $ 6,030,103 Denominator: Weighted average common shares outstanding 14,542,721 7,399,376 Effect of dilutive shares - 371,363 Diluted 14,542,721 7,770,738 Net income (loss) per common share: Basic $ (0.70 ) $ 0.81 Diluted $ (0.70 ) $ 0.78 For the three months ended March 31, 2020, the convertible instruments are anti-dilutive and therefore, have been excluded from earnings (loss) per share.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 11: SUBSEQUENT EVENTS Subsequent to March 31, 2020, the following transactions occurred: ● On April 01, 2020, the Company issued 4,666 shares of its Series A Preferred Stock to its president/chief executive officer, Jason Remillard, as additional compensation. ● On April 02, 2020, the Company converted $20,000 of a promissory note into 1,333,333 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On April 02, 2020, the Company converted $4,521.33 of a promissory note into 301,422 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On April 03, 2020, the Company converted $17,460 of a promissory note into 970,000 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On April 14, 2020, the Company converted $6,471.33 of a promissory note into 431,422 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On April 15, 2020, the Company amended its Articles of Incorporation to increase the number of shares of authorized common stock to 750,000,000. ● On April 16, 2020, the Company converted $6,793.83 of a promissory note into 452,922 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On April 16, 2020, the Company filed Form S-8 to register an additional 20,000,000 shares of its common stock under the S-8 filed with the SEC on May 20, 2019 (SEC File No. 333-231615). ● On April 17, 2020 the Company issued a total of 11,935,000 shares of its common stock to twelve (12) individuals, each of whom was either an employee or services provider to the Company. The shares were issued under the Company’s S-8 filed with the SEC on May 20, 2019 (SEC File No. 333-231615). ● On April 22, 2020, the Company converted $20,000 of a promissory note into 1,388,888 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On April 27, 2020, the Company received a $339,000 loan (the “PPP Loan”) through Silicon Valley Bank pursuant to the Paycheck Protection Program established under the Cares Act. The PPP Loan has a two-year term and bears interest at a rate of 1.0% per annum. Monthly principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The promissory note issued pursuant to the PPP Loan contains events of default and other provisions customary for a loan of this type. The PPP Loan may be forgiven if used under program parameters for payroll, mortgage interest and rent expenses. ● On April 27, 2020, the Company converted $19,922.10 of a promissory note into 1,811,100 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On April 28, 2020 the Company issued a total of 1,496,516 shares of its common stock to three persons who had previously invested $1,775,000 in the Company though the Company had not yet issued them their respective shares. These shares were issued for this prior investment, and the issuance was exempt under Section 4(a)(2) of the Securities Act. ● On April 28, 2020, the Company converted $24,540 of a promissory note into 1,804,411 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On May 02, 2020, the Company converted $15,600 of a promissory note into 2,000,000 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On May 06, the Company converted $10,080 of a promissory note into 1,680,000 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On May 06, the Company converted $8,490.72 of a promissory note into 2,166,000 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On May 07, the Company converted $11,494.90 of a promissory note into 2,357,929 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act. ● On May 12, the Company converted $14,700 of a promissory note into 2,450,000 shares of its common stock. The issuance was exempt under Section 4(a)(2) of the Securities Act.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Business Description	Business Description Data443 Risk Mitigation, Inc. (the “Company”) was incorporated as a Nevada corporation on May 4, 1998. The Company is developing products that enable secure data, at rest and in flight, across local devices, network, cloud, and databases. On October 15, 2019, the Company changed its name from LandStar, Inc. to Data443 Risk Mitigation, Inc. within the state of Nevada.
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements as of March 31, 2020 include the accounts of the Company and its wholly-owned subsidiary, Data 443 Risk Mitigation, Inc., a North Carolina operating company, and the operations of Myriad Software Productions, LLC through September 2018 when it was liquidated. Prior to the acquisition of Data 443 Risk Mitigation, Inc. in North Carolina and the assets of Myriad Software Productions, LLC in 2018, these two entities were controlled by our sole director and officer, Jason Remillard. On November 17, 2017, Mr. Remillard acquired control of DATA443 RISK MITIGATION, INC. through his purchase of all the outstanding Series A preferred shares of the Company, and as a result, these two entities became common controlled entities that require consolidation of results with the reporting company, DATA443 RISK MITIGATION, INC., from the time common control occurred. All intercompany accounts and activities have been eliminated. These consolidated financial statements have been prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”).
Interim Financial Statements	Interim Financial Statements These unaudited consolidated financial statements have been prepared in accordance U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2019 and notes thereto and other pertinent information contained in our Form 10-K the Company has filed with the Securities and Exchange Commission (the “SEC”) on April 17, 2020. The results of operations for the three months ended March 31, 2020, are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2020.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition	Revenue Recognition The Company derives revenue primarily from contracts for subscription to access our SaaS platforms and, to a much lesser degree, ancillary services provided in connection with subscription services. The Company’s contracts include the performance obligations that require us to provide access to the platforms, usually on an annual subscription. The Company’s contracts are for subscriptions to DataExpress TM TM TM TM Revenue related to contracts with customers is evaluated utilizing the following steps: (i) Identify the contract, or contracts, with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; (v) Recognize revenue when the Company satisfies a performance obligation.
Deferred Revenue	Deferred Revenue Deferred revenue mostly consists of service subscriptions received from users in advance of revenue recognition. The deferred revenue balance for the period ended March 31, 2020 was driven by cash payments from customers in advance of satisfying our performance obligations, offset by revenue recognized that was included in the deferred revenue balance at the beginning of the period.
Convertible Financial Instruments	Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP. When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument. Common stock purchase warrants and derivative financial instruments - Beneficial Conversion Feature
Share-Based Compensation	Share-Based Compensation Employees Nonemployees The Company recorded $205,652 in share-based compensation expense for the three months ended March 31, 2020, compared to $45,007 in share-based compensation expense for the three months ended March 31, 2019.
Fair Value Measurements	Fair Value Measurements The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows: ● Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets; ● Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and ● Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions. The Company’s financial instruments, including cash, accounts receivable, accounts payable, note payable, due to related parties and accrued liabilities, are carried at historical cost. At March 31, 2020 and December 31, 2019, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Management determined that liabilities created by beneficial conversion features associated with the issuance of certain convertible notes payable (see Note 6), meet the criteria of derivatives and are required to be measured at fair value. The fair value of these derivative liabilities was determined based on management’s estimate of the expected future cash flows required to settle the liabilities. This valuation technique involves management’s estimates and judgment based on unobservable inputs and is classified in level 3.
Basic and Diluted Net Income (Loss) Per Common Share	Basic and Diluted Net Income (Loss) Per Common Share Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and as if converted method. Dilutive potential common shares include outstanding stock options, warrant and convertible notes. For the three months ended March 31, 2020 and 2019, respectively, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. March 31, 2020 2019 Stock option 466,672 179,443 Warrants 69,714,754 - Convertible notes 144,106,172 2,625,093 214,287,598 2,804,536
Covid-19	COVID-19 A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company has instituted some and may take additional temporary precautionary measures intended to help ensure the well-being of its employees and minimize business disruption. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at March 31, 2020. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to collect accounts receivable and procure materials and supplies.
Cares Act	CARES Act The Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was enacted on March 27, 2020. There are several different provisions of the CARES Act that impact income taxes for corporations. While the Company continues to evaluate the tax implications, it believes these provisions will not have a material impact to the financial statements. Additionally, the Company has applied for, and has received, funds under the Paycheck Protection Program (the “PPP Loan”) after the period covered in these financial statements in the amount of $339,000. The receipt of these funds, and the forgiveness of the loan attendant to these funds, is dependent on the Company having initially qualified for the loan and qualifying for the forgiveness of such loan based on its future adherence to the forgiveness criteria. The PPP Loan has a two-year term and bears interest at a rate of 1.0% per annum. Monthly principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The promissory note executed by the Company in connection with the PPP Loan contains events of default and other provisions customary for a loan of this type. The PPP Loan is being used to retain the Company’s employees and allow them to be able to continue to provide essential services for the customers of the Company. Proceeds of the PPP Loan may also be used for other purposes permitted under applicable terms of the PPP. Certain prior period balances have been reclassed to conform with the current period presentation.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Schedule of Anti-dilutive Basic and Diluted Earnings Per Share	For the three months ended March 31, 2020 and 2019, respectively, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. March 31, 2020 2019 Stock option 466,672 179,443 Warrants 69,714,754 - Convertible notes 144,106,172 2,625,093 214,287,598 2,804,536

Intellectual Property (Tables)

Intellectual Property (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intellectual Property	The following table summarizes the components of the Company’s intellectual property as of the dates presented: March 31, December 31, 2020 2019 Intellectual property: Word press GDPR rights $ 46,800 $ 46,800 ARALOC™ 1,850,000 1,850,000 ArcMail License 1,445,000 1,445,000 DataExpressTM 1,388,051 1,388,051 4,729,851 4,729,851 Accumulated amortization (2,026,851 ) (1,587,913 ) Intellectual property, net of accumulated amortization $ 2,703,000 $ 3,141,938
Schedule of Future Amortization Expense of Intangible Assets	Based on the carrying value of definite-lived intangible assets as of March 31, 2020, we estimate our amortization expense for the next five years will be as follows: Amortization Year Ended December 31, Expense 2020 (excluding the three months ended March 31, 2020) $ 915,428 2021 792,422 2022 686,816 2023 308,333 2024 -

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Schedule of Future Minimum Lease Payments Under Operating Leases	Future minimum lease payments under operating leases that have initial non-cancelable lease terms in excess of one year at March 31, 2020 were as follows: Year Ended December 31, 2020 (excluding the three months ended March 31, 2020) $ 90,000 2021 123,600 2022 127,300 2023 131,150 2024 45,033 Thereafter - 517,083 Less: Imputed interest (78,662 ) Operating lease liabilities 438,421 Operating lease liability – current 89,017 Operating lease liability - non-current $ 349,404
Schedule of Other Supplemental Information Under Operating Lease	The following summarizes other supplemental information about the Company’s operating lease as of March 31, 2020: Weighted average discount rate 8 % Weighted average remaining lease term (years) 4.11
Schedule of Future Minimum Lease Payments Under Finance Leases	At March 31, 2020, future minimum lease payments under the capital lease obligations, are as follows: Year Ended December 31, 2020 (excluding the three months ended March 31, 2020) $ 79,573 2021 106,097 2022 78,197 2023 15,744 Thereafter - 279,611 Less: Imputed interest (41,926 ) Finance lease liabilities 237,685 Finance lease liability – current 81,987 Finance lease liability - non-current $ 155,698

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of Convertible Notes Payable	Convertible notes payable consists of the following: March 31, December 31, 2020 2019 Convertible Note - originated in September 2018 $ 1,400,000 $ 1,700,000 Convertible Note - originated in October 2018 294,150 444,150 Convertible Note - originated in October 2018 608,850 608,850 Convertible Note - originated in April 2019 519,000 600,000 Convertible Note - originated in June 2019 - 63,000 Convertible Note - originated in November 2019 38,000 38,000 Convertible Note - originated in December 2019 38,000 38,000 Convertible Notes - originated in January 2020 200,000 - Convertible Notes - originated in March 2020 136,250 - Convertible Notes - originated in March 2020 78,750 - Convertible Notes - originated in October 2018 (replacement) 135,000 - Convertible Notes - originated in March 2020 125,000 - 3,573,000 3,492,000 Less debt discount and debt issuance cost (412,620 ) (279,214 ) 3,160,380 3,212,786 Less current portion of convertible notes payable 3,160,380 3,212,786 Long-term convertible notes payable $ - $ -

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Value of Liabilities Measured on Recurring Basis	For the period ended March 31, 2020 and the year ended December 31, 2019, the estimated fair values of the liabilities measured on a recurring basis are as follows: Three Months Ended Year Ended March 31, December 31, 2020 2019 Expected term 0.02 - 5.00 years 0.25 - 5.00 years Expected average volatility 187%- 345 % 160%- 305 % Expected dividend yield - - Risk-free interest rate 0.01% - 1.57 % 1.55% - 2.50 %
Schedule of Changes in Derivative Liabilities	The following table summarizes the changes in the derivative liabilities during the period ended March 31, 2020: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Derivative liability as of December 31, 2019 $ 2,601,277 Addition of new derivatives recognized as debt discounts 500,675 Addition of new derivatives recognized as day-one loss 5,592,194 Addition of new derivatives recognized upon issuance of warrant - Derivative liabilities settled upon conversion of convertible note (896,839 ) Reclassification from APIC to derivative due to tainted instruments - Change in derivative liabilities recognized as loss on derivative 2,913,957 Derivative liability as of March 31, 2020 $ 10,711,264

Capital Stock and Reverse Sto_2

Capital Stock and Reverse Stock Split (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Summary of Warrants Activity	A summary of activity during the period ended March 31, 2020 follows: Warrants Outstanding Weighted Average Shares Exercise Price Outstanding, December 31, 2019 1,873,684 $ 0.491 Granted 250,000 - Reset feature 67,591,070 0.015 Exercised - - Forfeited/canceled - - Outstanding, March 31, 2020 69,714,754 $ 0.015
Schedule of Outstanding and Exercisable Warrants	The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2020: Warrants Outstanding Warrants Exercisable Weighted Average Number of Contractual life Weighted Average Number of Weighted Average 10,080,646 3.70 $ 0.02 10,080,646 $ 0.02 42,226,702 3.85 $ 0.02 42,226,702 $ 0.02 9,074,073 4.28 $ 0.02 9,074,073 $ 0.02 8,333,333 4.97 $ 0.02 8,333,333 $ 0.02 69,714,754 4.02 $ 0.02 61,381,421 $ 0.02

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	The following summarizes the stock option activity for the three months ended March 31, 2020: Options Outstanding Weighted-Average Balance as of December 31, 2019 377,227 $ 1.86 Grants of stock options 159,767 0.26 Cancelled stock options (70,316 ) 1.10 Balance as of March 31, 2020 466,678 $ 1.38
Schedule of Weighted Average Assumptions for Stock Options Granted	The fair value of each stock option is estimated on the date of grant using the Black-Scholes-Merton option pricing model with the following weighted average assumptions for stock options granted during the three months ended March 31, 2020: Expected term (years) 5.8 Expected stock price volatility 516.41 % Weighted-average risk-free interest rate 0.53 % Expected dividend $ 0.00
Schedule of Stock Options Vested and Expected to Vest	The following summarizes certain information about stock options vested and expected to vest as of March 31, 2020: Number of Weighted-Average Remaining Contractual Life Weighted-Average Options (In Years) Exercise Price Outstanding 466,678 8.54 $ 1.38 Exercisable 126,926 5.82 3.63 Expected to vest 339,746 9.55 $ 0.54
Schedule of Restricted Stock Activity	The following summarizes the restricted stock activity for the three months ended March 31, 2020: Weighted-Average Shares Fair Value Balance as of December 31, 2019 524,337 $ 0.79 Shares of restricted stock granted 25,000 0.78 Exercised - 1.67 Cancelled (72,145 ) 0.95 Balance as of March 31, 2020 477,192 $ 0.79
Schedule of Restricted Stock Award	March 31, December 31, Number of Restricted Stock Awards 2020 2019 Vested 100,978 57,243 Non-vested 376,214 467,094

Net Income Per Common Share (Ta

Net Income Per Common Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of Net Income Per Common Share	. Antidilutive stock awards consist of stock options that would have been antidilutive in the application of the treasury stock method. Three months ended March 31, 2020 2019 Numerator: Net income (loss) $ (10,157,643 ) $ 6,030,103 Denominator: Weighted average common shares outstanding 14,542,721 7,399,376 Effect of dilutive shares - 371,363 Diluted 14,542,721 7,770,738 Net income (loss) per common share: Basic $ (0.70 ) $ 0.81 Diluted $ (0.70 ) $ 0.78

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Mar. 27, 2020	Mar. 31, 2020	Mar. 31, 2019
Share-based compensation expense		$ 205,652	$ 45,007
Paycheck Protection Program [Member]
Proceeds from loans	$ 339,000
Debt instrument term	2 years
Debt interest rate	1.00%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Anti-dilutive Basic and Diluted Earnings Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Antidilutive Earnings Per Share	214,287,598	2,804,536
Stock Options [Member]
Antidilutive Earnings Per Share	466,672	179,443
Warrants [Member]
Antidilutive Earnings Per Share	69,714,754
Convertible Notes [Member]
Antidilutive Earnings Per Share	144,106,172	2,625,093

Intellectual Property (Details

Intellectual Property (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 438,938	$ 253,000

Intellectual Property - Schedul

Intellectual Property - Schedule of Intellectual Property (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Intellectual property	$ 4,729,851	$ 4,729,851
Accumulated amortization	(2,026,851)	(1,587,913)
Intellectual property, net of accumulated amortization	2,703,000	3,141,938
Word Press GDPR Rights [Member]
Intellectual property	46,800	46,800
ARALOC™ [Member]
Intellectual property	1,850,000	1,850,000
ArcMail License [Member]
Intellectual property	1,445,000	1,445,000
DataExpress™ [Member]
Intellectual property	$ 1,388,051	$ 1,388,051

Intellectual Property - Sched_2

Intellectual Property - Schedule of Future Amortization Expense of Intangible Assets (Details)	Mar. 31, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2020 (excluding the three months ended March 31, 2020)	$ 915,428
2021	792,422
2022	686,816
2023	308,333
2024

Leases (Details Narrative)

Leases (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Operating lease expire year	Operating leases for our office facility that expire in 2024.
Recognized lease expense	$ 27,871	$ 27,871
Capital lease term	3 years
Capital leases annual interest rate	12.00%
Capital lease obligations current	$ 81,987		$ 34,425
Capital lease obligations noncurrent	155,698		53,480
Operating Lease [Member]
Security deposit	$ 10,000		$ 10,000

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Payments Under Operating Leases (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Leases [Abstract]
2020 (excluding the three months ended March 31, 2020)	$ 90,000
2021	123,600
2022	127,300
2023	131,150
2024	45,033
Thereafter
Total lease payment	517,083
Less: Imputed interest	(78,662)
Operating lease liabilities	438,421
Operating lease liability - current	89,017	$ 86,372
Operating lease liability - non-current	$ 349,404	$ 373,000

Leases - Schedule of Other Supp

Leases - Schedule of Other Supplemental Information Under Operating Lease (Details)	Mar. 31, 2020
Leases [Abstract]
Weighted average discount rate	8.00%
Weighted average remaining lease term (years)	4 years 1 month 9 days

Leases - Schedule of Future M_2

Leases - Schedule of Future Minimum Lease Payments Under Finance Leases (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Leases [Abstract]
2020 (excluding the three months ended March 31, 2020)	$ 79,573
2021	106,097
2022	78,197
2023	15,744
Thereafter
Total finance lease payment	279,611
Less: Imputed interest	(41,926)
Finance lease liabilities	237,685
Finance lease liability	81,987	$ 34,425
Finance lease liability - non-current	$ 155,698	$ 53,480

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative)	3 Months Ended		12 Months Ended
	Mar. 31, 2020USD ($)$ / sharesshares	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)$ / shares
Interest expense	$ 53,517	$ 26,157
Amortization of debt discount	437,639	273,742
Repayments for related aprty	160,725
Derivative liability	500,675
Proceeds from convertible debt	497,250
Convertible outstanding amount	3,160,380		$ 3,212,786
Fair value of derivative liability	6,092,869
Loss on derivative	5,592,194
CEO [Member]
Debt instrument principal amount	81,000
Repayments for related aprty	135,000
Due to related party	135,000
Loss on settlement of debt	54,000
Convertible Note [Member]
Debt converted into common stock	$ 427,671
Debt converted into common stock, shares | shares	6,824,272
Derivative liability	$ 896,839
Convertible Note [Member] | Lender [Member]
Debt instrument principal amount	150,000
Promissory Notes - Issued in Fiscal Year 2018 [Member]
Loss on settlement of debt			$ 1,206,329
Debt interest rate			12.00%
Debt instrument maturity date, description			(i) January 12, 2020 or April 15, 2020 or (ii) any event of default under the note.
Debt conversion, description			The conversion price shall be equal to 60% of the lesser of the lowest trading price of the Company's common stock for (i) the 20 days immediately preceding December 31, 2019 or (ii) the 20 days immediately preceding the date of conversion.
Convertible outstanding amount			$ 739,000
Promissory Notes - Issued in Fiscal Year 2018 [Member] | Minimum [Member]
Debt instrument term			4 months
Promissory Notes - Issued in Fiscal Year 2018 [Member] | Maximum [Member]
Debt instrument term			15 months
Promissory Notes - Issued in Fiscal Year 2019 [Member]
Debt instrument principal amount			$ 15,000
Debt instrument term			12 months
Debt instrument maturity date, description			Convertible at the option of the holders at 4 months or 180 days after issuance date.
Debt conversion, description			Conversion prices are typically based on the discounted (39% to 50% discount) average closing prices or lowest trading prices of the Company's shares during various periods prior to conversion.
Debt instrument price rate			0.10
Debt conversion price | $ / shares			$ 0.005
Debt instrument penalty fees			$ 15,000
Financing costs			63,000
Proceeds from convertible debt			$ 676,000
Promissory Notes - Issued in Fiscal Year 2019 [Member] | Minimum [Member]
Debt interest rate			10.00%
Debt instrument price rate			0.50
Promissory Notes - Issued in Fiscal Year 2019 [Member] | Maximum [Member]
Debt interest rate			12.00%
Debt instrument price rate			0.60
Promissory Notes - Issued in Fiscal Year 2020 [Member]
Debt instrument principal amount	$ 15,000
Debt instrument maturity date, description	Convertible at the option of the holders at issuance date or 6 months after issuance date.
Debt conversion, description	Conversion prices are typically based on the discounted (35% to 50% discount) average closing prices or lowest trading prices of the Company's shares during various periods prior to conversion. Certain note has a fixed conversion price of $0.5 for a first 5 months
Debt instrument price rate	0.18
Debt conversion price | $ / shares	$ 0.01
Convertible outstanding amount	$ 540,000
Promissory Notes - Issued in Fiscal Year 2020 [Member] | Minimum [Member]
Debt instrument term	9 months
Debt interest rate	10.00%
Promissory Notes - Issued in Fiscal Year 2020 [Member] | Maximum [Member]
Debt instrument term	12 years
Debt interest rate	12.00%

Convertible Notes Payable - Sch

Convertible Notes Payable - Schedule of Convertible Notes Payable (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Convertible notes payable, Gross	$ 3,573,000	$ 3,492,000
Debt discount and debt issuance cost	(412,620)	(279,214)
Convertible notes payable	3,160,380	3,212,786
Less current portion of convertible notes payable	3,160,380	3,212,786
Long-term convertible notes payable
Originated in September 2018 [Member]
Convertible notes payable, Gross	1,400,000	1,700,000
Originated in October 2018 [Member]
Convertible notes payable, Gross	294,150	444,150
Originated in October 2018 [Member]
Convertible notes payable, Gross	608,850	608,850
Originated in April 2019 [Member]
Convertible notes payable, Gross	519,000	600,000
Originated in June 2019 [Member]
Convertible notes payable, Gross		63,000
Originated in November 2019 [Member]
Convertible notes payable, Gross	38,000	38,000
Originated in December 2019 [Member]
Convertible notes payable, Gross	38,000	38,000
Originated in January 2020 [Member]
Convertible notes payable, Gross	200,000
Originated in March 2020 [Member]
Convertible notes payable, Gross	136,250
Originated in March 2020 [Member]
Convertible notes payable, Gross	78,750
Originated in October 2018 (Replacement) [Member]
Convertible notes payable, Gross	135,000
Originated in March 2020 [Member]
Convertible notes payable, Gross	$ 125,000

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative, gain (loss) on derivative, net	$ (8,506,151)	$ 6,813,153

Derivative Liabilities - Schedu

Derivative Liabilities - Schedule of Fair Value of Liabilities Measured on Recurring Basis (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Expected Dividend Yield [Member]
Derivative liability, measurement input	0	0
Minimum [Member] | Measurement Input, Expected Term [Member]
Expected term	7 days	2 months 30 days
Minimum [Member] | Expected Average Volatility [Member]
Derivative liability, measurement input	187	160
Minimum [Member] | Risk Free Interest Rate [Member]
Derivative liability, measurement input	0.01	1.55
Maximum [Member] | Measurement Input, Expected Term [Member]
Expected term	5 years	5 years
Maximum [Member] | Expected Average Volatility [Member]
Derivative liability, measurement input	345	305
Maximum [Member] | Risk Free Interest Rate [Member]
Derivative liability, measurement input	1.57	2.50

Derivative Liabilities - Sche_2

Derivative Liabilities - Schedule of Changes in Derivative Liabilities (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Change in derivative liabilities recognized as loss on derivative	$ (8,506,151)	$ 6,813,153
Derivative liability ending	500,675
Fair Value, Inputs, Level 3 [Member]
Derivative liability beginning	2,601,277
Addition of new derivatives recognized as debt discounts	500,675
Addition of new derivatives recognized as day-one loss	5,592,194
Addition of new derivatives recognized upon issuance of warrant
Derivative liabilities settled upon conversion of convertible note	(896,839)
Reclassification from APIC to derivative due to tainted instruments
Change in derivative liabilities recognized as loss on derivative	2,913,957
Derivative liability ending	$ 10,711,264

Capital Stock and Reverse Sto_3

Capital Stock and Reverse Stock Split (Details Narrative) - $ / shares	Oct. 14, 2019	Mar. 31, 2020	Mar. 31, 2019	Mar. 05, 2020	Dec. 31, 2019
Reverse stock split	1-for-750
Common stock, shares authorized		250,000,000		250,000,000	250,000,000
Preferred stock, shares authorized		337,500			337,500
Preferred stock, par value	$ 0.001	$ 0.001			$ 0.001
Preferred stock, shares issued		1,334			1,334
Preferred stock, shares outstanding		1,334			1,334
Common stock, par value		$ 0.001			$ 0.001
Common stock, shares issued		19,482,091			9,692,065
Common stock, shares outstanding		19,482,091			9,692,065
Share-based compensation, shares		159,767
Warrants exercisable		69,714,754			1,873,684
Warrants weighted average exercise price		$ 0.015			$ 0.491
Common Stock [Member]
Common stock issued for conversion of debt		6,824,272	557,942
Stock issued for asset acquisition, shares		2,465,754
Share-based compensation, shares		500,000
Warrant [Member]
Number of warrants to acquire common stock		250,000
Warrants term		5 years
Warrants exercise price		$ 0.50
Increase in warrants		67,591,070
Warrants exercisable		69,714,754
Warrants weighted average exercise price		$ 0.015
Series A Preferred Stock [Member]
Preferred stock, designated shares		337,500
Preferred stock, shares issued		1,334			1,334
Preferred stock, shares outstanding		1,334			1,334
Debt converted of common stock, shares		15,000
Preferred stock voting rights		Entitled to vote 15,000 shares of common stock on all matters submitted to a vote by shareholders voting common stock.

Capital Stock and Reverse Sto_4

Capital Stock and Reverse Stock Split - Summary of Warrants Activity (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Equity [Abstract]
Warrants Outstanding Beginning balance, Shares | shares	1,873,684
Warrants Granted, Shares | shares	250,000
Warrants Reset feature, Shares | shares	67,591,070
Warrants Exercised, Shares | shares
Warrants Forfeited/canceled, Shares | shares
Warrants Outstanding Ending balance, Shares | shares	69,714,754
Warrants Outstanding Beginning balance, Weighted Average Exercise Price | $ / shares	$ 0.491
Warrants Granted, Weighted Average Exercise Price | $ / shares
Warrants Reset feature, Weighted Average Exercise Price | $ / shares	0.015
Warrants Exercised, Weighted Average Exercise Price | $ / shares
Warrants Forfeited/canceled, Weighted Average Exercise Price | $ / shares
Warrants Outstanding Ending balance, Weighted Average Exercise Price | $ / shares	$ 0.015

Capital Stock and Reverse Sto_5

Capital Stock and Reverse Stock Split - Schedule of Outstanding and Exercisable Warrants (Details) - $ / shares	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Number of Shares, Warrants Outstanding	69,714,754	1,873,684
Weighted Average Remaining Contractual life, Warrants Outstanding	4 years 7 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.02
Number of Shares, Warrants Exercisable	61,381,421
Weighted Average Exercise Price, Warrants Exercisable	$ 0.02
Warrant One [Member]
Number of Shares, Warrants Outstanding	10,080,646
Weighted Average Remaining Contractual life, Warrants Outstanding	3 years 8 months 12 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.02
Number of Shares, Warrants Exercisable	10,080,646
Weighted Average Exercise Price, Warrants Exercisable	$ 0.02
Warrant Two [Member]
Number of Shares, Warrants Outstanding	42,226,702
Weighted Average Remaining Contractual life, Warrants Outstanding	3 years 10 months 6 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.02
Number of Shares, Warrants Exercisable	42,226,702
Weighted Average Exercise Price, Warrants Exercisable	$ 0.02
Warrant Three [Member]
Number of Shares, Warrants Outstanding	9,074,073
Weighted Average Remaining Contractual life, Warrants Outstanding	4 years 3 months 11 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.02
Number of Shares, Warrants Exercisable	9,074,073
Weighted Average Exercise Price, Warrants Exercisable	$ 0.02
Warrant Four [Member]
Number of Shares, Warrants Outstanding	8,333,333
Weighted Average Remaining Contractual life, Warrants Outstanding	4 years 11 months 19 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.02
Number of Shares, Warrants Exercisable	8,333,333
Weighted Average Exercise Price, Warrants Exercisable	$ 0.02

Share-Based Compensation (Detai

Share-Based Compensation (Details Narrative) - Stock Options [Member] - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based compensation, vesting period	1 year
Share-based compensation, expiration term	10 years
Weighted average granted date fair value stock options granted	$ 1.35
Fair value of option vested	$ 46,638
Unrecognized compensation and non-vested	$ 65,248	$ 18,229

Share-Based Compensation - Sche

Share-Based Compensation - Schedule of Stock Option Activity (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Share-based Payment Arrangement [Abstract]
Options Outstanding, Balance Beginning | shares	377,227
Options Outstanding, Grants of stock options | shares	159,767
Options Outstanding, Cancelled stock options | shares	(70,316)
Options Outstanding, Balance Ending | shares	466,678
Weighted-Average Exercise Price, Balance Beginning | $ / shares	$ 1.86
Weighted-Average Exercise Price, Grants of stock options | $ / shares	0.26
Weighted-Average Exercise Price, Cancelled stock options | $ / shares	1.10
Weighted-Average Exercise Price, Balance Ending | $ / shares	$ 1.38

Share-Based Compensation - Sc_2

Share-Based Compensation - Schedule of Weighted Average Assumptions for Stock Options Granted (Details) - Stock Options [Member]	3 Months Ended
	Mar. 31, 2020
Expected term (years)	5 years 9 months 18 days
Expected stock price volatility	516.41%
Weighted-average risk-free interest rate	0.53%
Expected dividend	0.00%

Share-Based Compensation - Sc_3

Share-Based Compensation - Schedule of Stock Options Vested and Expected to Vest (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Share-based Payment Arrangement [Abstract]
Number of Options, Outstanding | shares	466,678
Number of Options, Exercisable | shares	126,926
Number of Options, Expected to vest | shares	339,746
Weighted-Average Remaining Contractual Life (In Years), Outstanding	8 years 6 months 14 days
Weighted-Average Remaining Contractual Life (In Years), Exercisable	5 years 9 months 25 days
Weighted-Average Remaining Contractual Life (In Years), Expected to vest	9 years 6 months 18 days
Weighted-Average Exercise Price, Outstanding | $ / shares	$ 1.38
Weighted-Average Exercise Price, Exercisable | $ / shares	3.63
Weighted-Average Exercise Price, Expected to vest | $ / shares	$ 0.54

Share-Based Compensation - Sc_4

Share-Based Compensation - Schedule of Restricted Stock Activity (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Number of Restricted Stock, Exercised
Restricted Stock [Member]
Number of Restricted Stock, Balance Beginning	524,337
Number of Restricted Stock, Shares of restricted stock granted	25,000
Number of Restricted Stock, Exercised
Number of Restricted Stock, Cancelled	(72,145)
Number of Restricted Stock, Balance Ending	477,192
Weighted-Average Fair Value of Restricted Stock, Balance Beginning | $ / shares	$ 0.79
Weighted-Average Fair Value of Restricted Stock, Shares of restricted stock granted | $ / shares	0.78
Weighted-Average Fair Value of Restricted Stock, Exercised | $ / shares	1.67
Weighted-Average Fair Value of Restricted Stock, Cancelled | $ / shares	0.95
Weighted-Average Fair Value of Restricted Stock, Balance Ending | $ / shares	$ 0.79

Share-Based Compensation - Sc_5

Share-Based Compensation - Schedule of Restricted Stock Awards (Details) - Restricted Stock [Member] - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Number of Restricted Stock Awards, Vested	100,978	57,243
Number of Restricted Stock Awards, Non-vested	376,214	467,094

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Jan. 31, 2018	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Sep. 16, 2019
Due to related party		$ 1,160,793		$ 1,103,314
Repayment of notes payable		203,245	$ 225,000
Operating expenses		1,546,052	$ 905,391
CEO [Member]
Due to related party		135,000
Repayment of notes payable		135,000
Operating expenses		82,203
Repayment of debt		85,500
Convertible note		81,000
Prepayment penalty		54,000
Loss on settlement of debt		54,000
Asset Purchase Agreement [Member] | DMB Group LLC [Member]
Notes payable		715,441		$ 828,561	$ 940,000
Due to related party		75,225			$ 97,689
Repayment of notes payable		83,323
Interest expenses		$ 8,098
Mr. Remillard [Member]
Purchase consideration, common stock shares issuable	$ 1,600,000
Mr. Remillard [Member] | Myriad Software Productions, LLC [Member]
Ownership percentage	100.00%
Purchase consideration	$ 1,500,000
Purchase consideration, paid at closing	50,000
Purchase consideration, promissory note	250,000
Purchase consideration, common stock shares issuable	$ 1,200,000

Net Income Per Common Share - S

Net Income Per Common Share - Schedule of Net Income Per Common Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Numerator: Net income (loss)	$ (10,181,015)	$ 6,030,103
Denominator: Weighted average common shares outstanding	14,542,721	7,399,376
Denominator: Effect of dilutive shares		371,363
Denominator: Diluted	14,542,721	7,770,738
Net income (loss) per common share: Basic	$ (0.70)	$ 0.81
Net income (loss) per common share: Diluted	$ (0.70)	$ 0.78

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	May 12, 2020	May 07, 2020	May 06, 2020	May 06, 2020	May 02, 2020	Apr. 28, 2020	Apr. 27, 2020	Apr. 22, 2020	Apr. 17, 2020	Apr. 16, 2020	Apr. 14, 2020	Apr. 03, 2020	Apr. 02, 2020	Apr. 01, 2020	Mar. 27, 2020	Apr. 15, 2020	Mar. 31, 2020	Mar. 05, 2020	Dec. 31, 2019
Common stock, shares authorized																	250,000,000	250,000,000	250,000,000
Paycheck Protection Program [Member]
Proceeds from loans															$ 339,000
Debt instrument term															2 years
Debt interest rate															1.00%
Subsequent Event [Member]
Common stock, shares authorized																750,000,000
Additional shares of common stock										20,000,000
Subsequent Event [Member] | Paycheck Protection Program [Member]
Proceeds from loans							$ 339,000
Debt instrument term							2 years
Debt interest rate							1.00%
Subsequent Event [Member] | Promissory Note [Member]
Value of debt converted into common stock	$ 14,700	$ 11,495	$ 10,080	$ 8,491	$ 15,600	$ 24,540	$ 19,922	$ 20,000		$ 6,794	$ 6,471	$ 17,460	$ 20,000
Debt converted into common stock shares	2,450,000	2,357,929	1,680,000	2,166,000	2,000,000	1,804,411	1,811,100	1,388,888		452,922	431,422	970,000	1,333,333
Subsequent Event [Member] | Promissory Note [Member]
Value of debt converted into common stock													$ 4,521
Debt converted into common stock shares													301,422
Subsequent Event [Member] | Jason Remillard [Member]
Common stock shares issued during period														4,666
Subsequent Event [Member] | 12 Individuals [Member]
Number of common stock issued for services									11,935,000
Subsequent Event [Member] | Three Persons [Member]
Common stock shares issued during period						1,496,516
Common stock shares issued during period, value						$ 1,775,000